[Advanced Semiconductor Engineering, Inc. IR Contact : Iris Wu, Manager irissh_wu@aseglobal.com Tel: +886.2.6636.5678 http://www.aseglobal.com US contact: Echo Lin, Senior Associate echolin@iselabs.com +1.510.687.2491 Grace Teng, Manager grace_teng@aseglobal.com Tel: +886.2.6636.5678 ADVANCED SEMICON]
[This Form 6-K consists of: (Stock Code: 902) ISSUE OF SUPER SHORT-TERM DEBENTURES Listing Rules Company As resolved at the 2016 annual general meeting of Huaneng Power International, Inc. (the “ Debentures The Company has recently completed the issue of the fifth tranche of the Company’s super short]
[SOHU.COM INC. PAGE PART I FINANCIAL INFORMATION Item 1 Condensed Consolidated Financial Statements (unaudited) 3 Condensed Consolidated Balance Sheets as of December 31, 2017 and March 31, 2018 3 Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2017 and ]
[500.com Limited to Report First Quarter 2018 Financial Results on May 10, 2018 SHENZHEN, China, May 7, 2018 —500.com Limited (NYSE: WBAI) ("500.com" or the "Company"), a leading online sports lottery service provider in China, today announced that it will release its financial results for the first ]
[Fluent Announces First Quarter 2018 Financial Results First Quarter as a Standalone Public Company Produces $56.0 Million in Revenue, $2.2 Million in Adjusted Net Income Based on $5.6 Million in Net Loss from Continuing Operations, Resulting in $0.03 in Adjusted Earnings Per Share New York, NY – May]
[6-K FORM 13a-16 15d-16 000-51469 BAIDU, INC. Baidu Campus No. 10 Shangdi 10th Street Haidian District, Beijing 100085 The Peoples Republic of China 20-F 40-F. 20-F ☒ Form 40-F ☐ Form 6-K S-T 6-K S-T Transfer of Equity Interests in Rajax Holding by Baidu (Hong Kong) Limited Baidu HK Company Ali Baid]
[Sinovac Forced to Temporarily Suspend Hepatitis A Vaccine Production Line Due to Disruptive Actions taken by Minority Shareholder of Sinovac Beijing Actions of Aihua Pan continue to harm the Company’s shareholders and customers BEIJING, May 8, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ]
[*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information requir]
